TriangleNCT01302366 · OUTCOME
Percentage of Patients Who Have Responded to TBL12
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- Not reported
- Time frame
- 2 months
What was measured
Response to TBL12 is defined as SD or better after 2 cycles of TBL12. The evaluation of SD, PR, or CR is based on the report by Blade et al. (1998)
Analysis population: all patients
Groups in this outcome
Sea Cucumber Extract (TBL 12)
TBL12 is administered orally at a dose of 2 units (of 20 mL each) twice a day, in 4-week cycles, until disease progression or there is sign of disease progression.
| Group | Source count |
|---|---|
| Sea Cucumber Extract (TBL 12) | 20 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Sea Cucumber Extract (TBL 12) | 100 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 100
- denoms
- counts
- group Id
- OG000
- value
- 20
- units
- Participants
- description
- Response to TBL12 is defined as SD or better after 2 cycles of TBL12. The evaluation of SD, PR, or CR is based on the report by Blade et al. (1998)
- groups
- description
- TBL12 is administered orally at a dose of 2 units (of 20 mL each) twice a day, in 4-week cycles, until disease progression or there is sign of disease progression.
- id
- OG000
- title
- Sea Cucumber Extract (TBL 12)
- param Type
- NUMBER
- population Description
- all patients
- reporting Status
- POSTED
- time Frame
- 2 months
- title
- Percentage of Patients Who Have Responded to TBL12
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice